Cargando…
Impact of Blood–Brain Barrier to Delivering a Vascular-Disrupting Agent: Predictive Role of Multiparametric MRI in Rodent Craniofacial Metastasis Models
SIMPLE SUMMARY: The role of the blood–brain barrier in intracranial cancer treatment by vascular-disrupting agents remains unclear. Intraindividual comparison of vascular shutdown by a craniofacial metastasis model was performed, on the basis of in vivo MRI imaging, postmortem NanoCT and pathology a...
Autores principales: | Wang, Shuncong, Feng, Yuanbo, Chen, Lei, Yu, Jie, Li, Yue, Ni, Yicheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740057/ https://www.ncbi.nlm.nih.gov/pubmed/36497308 http://dx.doi.org/10.3390/cancers14235826 |
Ejemplares similares
-
Predicting Clinical Efficacy of Vascular Disrupting Agents in Rodent Models of Primary and Secondary Liver Cancers: An Overview with Imaging-Histopathology Correlation
por: Liu, Yewei, et al.
Publicado: (2020) -
Sequential Administrations of a Vascular-Disrupting Agent,
High-Intensity Focused Ultrasound, and a Radioactively labeled Necrosis Avid
Compound for Eradicating Solid Malignancies
por: Li, Yue, et al.
Publicado: (2022) -
Enhanced Antitumor Efficacy of a Vascular Disrupting Agent Combined with an Antiangiogenic in a Rat Liver Tumor Model Evaluated by Multiparametric MRI
por: Chen, Feng, et al.
Publicado: (2012) -
AI-based MRI auto-segmentation of brain tumor in rodents, a multicenter study
por: Wang, Shuncong, et al.
Publicado: (2023) -
Predicting Therapeutic Efficacy of Vascular Disrupting Agent CA4P in Rats with Liver Tumors by Hepatobiliary Contrast Agent Mn-DPDP-Enhanced MRI
por: Liu, Yewei, et al.
Publicado: (2019)